MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Cytonics.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Cytonics.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Cytonics.com most likely does not offer any adult content.
Popular pages
-
Home - New - Cytonics Corporation
Company Overview Cytonics is a biotechnology research and development company that specializes in developing diagnostics and therapeutics for osteoarthritis. Our flagship product was the Fibronectin-A...
-
Patients - Cytonics Corporation
Patients Patients dial 844-822-6444 or email info@axiomtherapies.com Over 30 million people are treated for back pain every year in the US, and osteoarthritis (OA) is the leading culprit affecting ove...
-
News - Cytonics Corporation
News A2M halts the progression of osteoarthritis at the molecular level by inactivating the chemicals that cause the joints to bre... ...
-
Technology - Cytonics Corporation
Technology The Problem Osteoarthritis (OA) is a crippling disease that is caused by the breakdown of cartilage within joints. While the exact cause of OA remains unknown, post-traumatic injuries (e.g...
-
Management - Cytonics Corporation
Management Founder & Chairman of the Board Gaetano Scuderi, MD is the Founder and Chairman of the Board of Cytonics Corporation. Dr. Scuderi is a fellowship-trained (UCSD, San Diego, CA) spine surgeon...
-
Cytonics Receives Feedback from the FDA on Pre-Clinical and Phase 1 Trial Designs for Cyt-108
NOVEMBER 2, 2018 Jupiter, FL: Cytonics Corporation received feedback on the pre-clinical and clinical trial designs for their recombinant Alpha-2-Macroglobulin (A2M) drug product, Cyt-108. The FDA tho...